Eagle Pharmaceuticals, Inc. (EGRX)

Eagle Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	74	380	658	607	821	601
Market Cap Growth	-55.03%	-42.14%	8.37%	-26.12%	36.70%	-24.62%
Enterprise Value	129	430	590	556	748	554
Last Close Price	19.44	29.23	50.92	46.57	60.08	40.29
PE Ratio	6.29	10.71	-77.03	53.53	59.49	19.28
PS Ratio	0.29	1.20	3.83	3.23	4.19	2.82
PB Ratio	0.29	1.63	3.73	3.26	4.58	3.74
P/FCF Ratio	-27.10	7.53	23.57	12.45	14.88	11.50
P/OCF Ratio	-27.31	7.50	23.30	12.26	14.67	11.47
EV/Sales Ratio	0.50	1.36	3.44	2.96	3.82	2.60
EV/EBITDA Ratio	2.26	3.82	90.30	15.24	29.56	11.05
EV/EBIT Ratio	3.66	4.28	212.92	16.88	34.30	11.92
EV/FCF Ratio	-33.17	8.51	21.13	11.41	13.55	10.60
Debt / Equity Ratio	0.29	0.28	0.15	0.18	0.22	0.28
Debt / EBITDA Ratio	1.14	0.57	3.39	0.91	1.46	0.89
Debt / FCF Ratio	-7.71	1.30	0.96	0.70	0.70	0.85
Asset Turnover	0.65	0.96	0.68	0.74	0.79	0.84
Inventory Turnover	1.55	2.72	2.81	6.21	8.19	9.23
Quick Ratio	1.51	1.15	1.87	4.05	4.06	3.66
Current Ratio	2.16	1.70	2.32	4.36	4.62	4.13
Return on Equity (ROE)	4.88%	17.39%	-4.76%	6.57%	8.42%	18.77%
Return on Assets (ROA)	6.63%	19.03%	0.68%	8.11%	5.53%	11.42%
Return on Capital (ROIC)	8.46%	24.99%	0.82%	9.40%	6.45%	13.44%
Earnings Yield	16.08%	9.37%	-1.31%	1.98%	1.74%	5.31%
FCF Yield	-12.64%	13.28%	4.24%	8.03%	6.72%	8.70%
Buyback Yield / Dilution	-2.48%	-0.11%	5.23%	2.60%	7.46%	3.96%
Total Shareholder Return	-2.48%	-0.11%	5.23%	2.60%	7.46%	3.96%

Source: S&P Capital IQ. Standard template.